Literature DB >> 1162985

Severe vasospasm following ergot administration.

L G Robb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1162985      PMCID： PMC1130393     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  27 in total

1.  ERGOTISM: REPORT OF A CASE STUDIED ARTERIOGRAPHICALLY.

Authors:  R A KRAMER; S P HECKER; B I LEWIS
Journal:  Radiology       Date:  1965-02       Impact factor: 11.105

2.  BLOOD VISCOSITY AND RAYNAUD'S DISEASE.

Authors:  R PRINGLE; D N WALDER; J P WEAVER
Journal:  Lancet       Date:  1965-05-22       Impact factor: 79.321

3.  Acute ischemia of a limb complicating methysergide maleate therapy.

Authors:  A L URELES; C ROB
Journal:  JAMA       Date:  1963-03-23       Impact factor: 56.272

4.  Ergotamine-induced peripheral arterial spasm: clinical and angiographic diagnosis.

Authors:  J Syme
Journal:  Australas Radiol       Date:  1971-02

5.  Ergotism: report of case with localized arteriographic changes in femoral vessel.

Authors:  C D Haynes; M E Davis
Journal:  Angiology       Date:  1968-04       Impact factor: 3.619

6.  Case of ergot poisoning.

Authors:  S T Yao; D P Goodwin; J R Kenyon
Journal:  Br Med J       Date:  1970-07-11

7.  Ergotamine poisoning producing renal arterial spasm.

Authors:  M S Fedotin; C Hartman
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

8.  Angiography in peripheral ischaemia due to ergotism. Report of two cases.

Authors:  D Sutton; B J Preston
Journal:  Br J Radiol       Date:  1970-11       Impact factor: 3.039

9.  Upper limb ischaemia due to ergotamine tartrate.

Authors:  R H Felix; J D Carroll
Journal:  Practitioner       Date:  1970-07

10.  Ergotism causing peripheral vascular ischemia.

Authors:  M G McLoughlin; R J Sanders
Journal:  Rocky Mt Med J       Date:  1972-02
View more
  1 in total

Review 1.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.